Skip to content
Riskpilot
← Back to search
Sign in
Get full access
LYNX PHARMA AS
AS
Active
Org 931174673
Brevikveien 48, 3135
Torød
Other human health activities n.e.c.
·
NACE 8699
Est. 2023 · 3 years old
0 employees
Monitor
Share
Norway
/
Companies
/
Other human health activities n.e.c.
/
LYNX PHARMA AS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
HA
Henrik Aasrum Svendsen
Chief Executive Officer
Chief Executive Officer
2023
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
AS
Ater-Arslan Sajid
Chairman
Chairman
2023
ET
Elias Tallay
Board of Directors
Board of Directors
2023
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Ytre Hattholmen As
Company
100%
100%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on LYNX PHARMA AS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
